TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial.
Saved in:
| Title: | TRIFLURIDINE/TIPIRACIL (FTD/TPI) with or without bevacizumab in previously treated patients with esophago-gastric adenocarcinoma, a randomised phase III trial. |
|---|---|
| Authors: | Baeksgaard Jensen L; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Yilmaz M; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Nordsmark M; Department of Oncology, Aarhus University Hospital, Denmark., Möller S; Odense Patient Data Explorative Network (OPEN), Odense University Hospital, Denmark., Elle IC; Department of Oncology, Odense University Hospital, Denmark., Ladekarl M; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark., Qvortrup C; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Pfeiffer P; Department of Oncology, Odense University Hospital, Denmark. |
| Source: | EClinicalMedicine [EClinicalMedicine] 2024 Mar 08; Vol. 70, pp. 102521. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2589-5370 |
|---|---|
| DOI: | 10.1016/j.eclinm.2024.102521 |
